Brain and Central Nervous System Tumors
Showing 1 - 25 of 403
Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- GDC-0084
- radiation therapy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 13, 2023
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- 54 Gy radiotherapy
- 60 Gy radiotherapy
-
Phoenix, Arizona
- +77 more
Dec 15, 2022
Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))
Active, not recruiting
- Brain and Central Nervous System Tumors
- BGB 324 (before surgery)
- BGB 324 (after surgery)
-
Birmingham, Alabama
- +5 more
Dec 1, 2022
Brain and CNS Tumors, Neurotoxicity Trial in United States (temozolomide, 3-dimensional conformal radiation therapy,
Active, not recruiting
- Brain and Central Nervous System Tumors
- Neurotoxicity
- temozolomide
- +2 more
-
Birmingham, Alabama
- +167 more
Aug 9, 2022
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Brain and CNS Tumors Trial in Worldwide (concomitant temozolomide (TMZ), radiotherapy, procarbazine)
Recruiting
- Brain and Central Nervous System Tumors
- concomitant temozolomide (TMZ)
- +5 more
-
Birmingham, Alabama
- +277 more
Mar 22, 2022
Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- filgrastim
- +5 more
-
Durham, North Carolina
- +8 more
Dec 17, 2021
Brain and CNS Tumors, Long-term Effects Secondary to Cancer Therapy in Children Trial in Boston (radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- Long-term Effects Secondary to Cancer Therapy in Children
- radiation therapy
-
Boston, MassachusettsMassachusetts General Hospital
Dec 3, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)
Completed
- Brain and Central Nervous System Tumors
- Glioblastoma Multiforme
- Celecoxib
- +3 more
-
Fort Smith, Arkansas
- +11 more
Sep 21, 2021
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
- Brain and Central Nervous System Tumors
- +10 more
- (no location specified)
Sep 20, 2021
Brain and CNS Tumors Trial in Cleveland (aminolevulinic acid, Surgical Resection)
Completed
- Brain and Central Nervous System Tumors
- aminolevulinic acid
- Surgical Resection
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 13, 2021
Brain and CNS Tumors Trial in United States (procarbazine HCl, thalidomide)
Completed
- Brain and Central Nervous System Tumors
- procarbazine hydrochloride
- thalidomide
-
Decatur, Illinois
- +4 more
Sep 7, 2021
Brain and CNS Tumors, Cognitive/Functional Effects, Depression Trial in United States (drug, procedure, radiation)
Terminated
- Brain and Central Nervous System Tumors
- +4 more
- methylphenidate hydrochloride
- +2 more
-
Phoenix, Arizona
- +6 more
Sep 7, 2021
Brain and CNS Tumors, Solid Tumor Trial in United States (temozolomide, thalidomide, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- Unspecified Adult Solid Tumor, Protocol Specific
- temozolomide
- +2 more
-
Decatur, Illinois
- +4 more
Sep 7, 2021
Brain and CNS Tumors, Radiation Toxicity Trial in United States (dietary supplement, drug, procedure)
Completed
- Brain and Central Nervous System Tumors
- Radiation Toxicity
- EGb761
- +2 more
-
Phoenix, Arizona
- +3 more
Sep 7, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Brain and CNS Tumors, Cognitive/Functional Effects, Fatigue Trial in United States (modafinil, )
Completed
- Brain and Central Nervous System Tumors
- +4 more
- modafinil
- placebo
-
Birmingham, Alabama
- +59 more
Jul 20, 2021
Brain and CNS Tumors Trial in San Francisco, New York, Cleveland (HSPPC-96, Standard Surgical Resection)
Completed
- Brain and Central Nervous System Tumors
- HSPPC-96
- Standard Surgical Resection
-
San Francisco, California
- +2 more
May 11, 2021
Brain and CNS Tumors Trial in United States (biological, drug, procedure)
Completed
- Brain and Central Nervous System Tumors
- HSPPC-96
- +2 more
-
San Francisco, California
- +8 more
Mar 23, 2021
Brain and CNS Tumors Trial in Geneva (adjuvant therapy, radiation therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- adjuvant therapy
- radiation therapy
-
Geneva, SwitzerlandHopital Cantonal Universitaire de Geneve
Feb 2, 2021